Reduced reproductive potential in young healthy women with hereditary breast and/or ovarian cancer syndrome

Authors: Giovanna Sighinolfi, Giovanni Grandi, Elena Barbieri, Marta Venturelli, Claudia Piombino, Chiara Melotti, Rebecca Lippi Bruni, Riccardo Costantini Cuoghi, Roberto D’Amico, Matteo Lambertini, Fedro A. Peccatori, Elena Tenedini, Massimo Dominici, Laura Cortesi, Antonio La Marca, Angela Toss

Source: Communications Medicine, Vol 5, Iss 1, Pp 1-9 (2025)

Subject Terms: Medicine

File Description: electronic resource

Relation: https://doaj.org/toc/2730-664X

Access URL: https://doaj.org/article/cffa830a74404097a10c0f7dcb174df1

Predictive factors for relapse in triple-negative breast cancer patients without pathological complete response after neoadjuvant chemotherapy

Authors: Angela Toss, Marta Venturelli, Monica Civallero, Claudia Piombino, Federica Domati, Guido Ficarra, Francesca Combi, Eleonora Cabitza, Federica Caggia, Elena Barbieri, Monica Barbolini, Luca Moscetti, Claudia Omarini, Federico Piacentini, Giovanni Tazzioli, Massimo Dominici, Laura Cortesi

Source: Frontiers in Oncology, Vol 12 (2022)

Subject Terms: triple-negative breast cancer, neoadjuvant chemotherapy, pathologic response, residual cancer burden (RCB), multifocal disease, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282

File Description: electronic resource

Relation: https://www.frontiersin.org/articles/10.3389/fonc.2022.1016295/full; https://doaj.org/toc/2234-943X

Access URL: https://doaj.org/article/817c65a0954542c8a81c9e2fe03455f1

BRCA mutation rate and characteristics of prostate tumor in breast and ovarian cancer families: analysis of 6,591 Italian pedigrees

Authors: Laura Cortesi, Federica Domati, Annalisa Guida, Isabella Marchi, Angela Toss, Elena Barbieri, Luigi Marcheselli, Marta Venturelli, Simonetta Piana, Claudia Cirilli, Massimo Federico

Source: Cancer Biology & Medicine, Vol 18, Iss 2, Pp 470-476 (2021)

Subject Terms: brca genes, prostate cancer, hereditary cancer, modena criteria, breast cancer, ovarian cancer, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282

File Description: electronic resource

Relation: http://www.cancerbiomed.org/index.php/cocr/article/view/1800; https://doaj.org/toc/2095-3941

Access URL: https://doaj.org/article/1ed86c517b2444a5ac6d5a3b36c3d2f6

Exceptional response to lurbinectedin and irinotecan in -mutated platinum-resistant ovarian cancer patient: a case report

Authors: Laura Cortesi, Marta Venturelli, Elena Barbieri, Cinzia Baldessari, Camilla Bardasi, Emanuele Coccia, Federica Baglio, Margherita Rimini, Stefano Greco, Martina Napolitano, Stefania Pipitone, Massimo Dominici

Source: Therapeutic Advances in Chronic Disease, Vol 13 (2022)

Subject Terms: Therapeutics. Pharmacology, RM1-950

File Description: electronic resource

Relation: https://doaj.org/toc/2040-6231

Access URL: https://doaj.org/article/8ff78bb318914fedb3fff36f01653e68

The Prognostic and Predictive Role of Somatic BRCA Mutations in Ovarian Cancer: Results from a Multicenter Cohort Study

Authors: Angela Toss, Claudia Piombino, Elena Tenedini, Alessandra Bologna, Elisa Gasparini, Vittoria Tarantino, Maria Elisabetta Filieri, Luca Cottafavi, Filippo Giovanardi, Stefano Madrigali, Monica Civallero, Luigi Marcheselli, Isabella Marchi, Federica Domati, Marta Venturelli, Elena Barbieri, Giovanni Grandi, Enrico Tagliafico, Laura Cortesi

Source: Diagnostics, Vol 11, Iss 3, p 565 (2021)

Subject Terms: BRCA, ovarian cancer, copy number variation, genetic testing, Medicine (General), R5-920

File Description: electronic resource

Relation: https://www.mdpi.com/2075-4418/11/3/565; https://doaj.org/toc/2075-4418

Access URL: https://doaj.org/article/9eec5d9a9b4f45449325e2c0246903d7